Nomura Holdings Inc. Sells 44,739 Shares of Sabra Healthcare REIT, Inc. $SBRA

Key Points

• Nomura Holdings Inc. significantly reduced its stake in Sabra Healthcare REIT by 78.5%, selling 44,739 shares and now holding only 12,287 shares valued at approximately $215,000.
• Multiple analysts have raised their price targets for Sabra Healthcare REIT, with a consensus average price target now at $20.71, indicating a positive market outlook for the stock.
• Sabra Healthcare REIT's latest earnings report exceeded expectations, posting a $0.38 earnings per share and a revenue increase of 7.4% from the previous year, along with a 6.3% dividend yield.

Nomura Holdings Inc. cut its position in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Free Report) by 78.5% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 12,287 shares of the real estate investment trust's stock after selling 44,739 shares during the quarter. Nomura Holdings Inc.'s holdings in Sabra Healthcare REIT were worth $215,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. Canada Pension Plan Investment Board grew its position in shares of Sabra Healthcare REIT by 97.8% in the 1st quarter. Canada Pension Plan Investment Board now owns 392,100 shares of the real estate investment trust's stock valued at $6,850,000 after buying an additional 193,900 shares during the last quarter. Te Ahumairangi Investment Management Ltd grew its position in shares of Sabra Healthcare REIT by 14.2% in the first quarter. Te Ahumairangi Investment Management Ltd now owns 127,106 shares of the real estate investment trust's stock valued at $2,221,000 after purchasing an additional 15,800 shares in the last quarter. State of Wyoming boosted its stake in Sabra Healthcare REIT by 26.4% during the first quarter. State of Wyoming now owns 20,270 shares of the real estate investment trust's stock valued at $354,000 after buying an additional 4,229 shares during the period. Wealth Preservation Advisors LLC bought a new stake in Sabra Healthcare REIT during the first quarter worth about $38,000. Finally, Samalin Investment Counsel LLC lifted its stake in Sabra Healthcare REIT by 46.8% during the first quarter. Samalin Investment Counsel LLC now owns 20,925 shares of the real estate investment trust's stock worth $366,000 after purchasing an additional 6,668 shares during the last quarter. Institutional investors and hedge funds own 99.40% of the company's stock.

Sabra Healthcare REIT Stock Down 0.4%

Shares of SBRA stock traded down $0.08 during midday trading on Thursday, reaching $18.86. 234,906 shares of the stock were exchanged, compared to its average volume of 2,433,898. Sabra Healthcare REIT, Inc. has a 1 year low of $15.60 and a 1 year high of $20.03. The company's 50 day moving average is $18.67 and its two-hundred day moving average is $17.93. The company has a current ratio of 4.80, a quick ratio of 4.80 and a debt-to-equity ratio of 0.91. The firm has a market cap of $4.52 billion, a PE ratio of 24.86, a price-to-earnings-growth ratio of 1.52 and a beta of 0.88.

Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last posted its earnings results on Monday, August 4th. The real estate investment trust reported $0.38 earnings per share for the quarter, topping analysts' consensus estimates of $0.36 by $0.02. Sabra Healthcare REIT had a return on equity of 6.69% and a net margin of 24.87%.The firm had revenue of $189.15 million for the quarter, compared to the consensus estimate of $185.64 million. During the same quarter in the prior year, the business earned $0.36 EPS. The business's revenue for the quarter was up 7.4% on a year-over-year basis. Sabra Healthcare REIT has set its FY 2025 guidance at 1.450-1.470 EPS. On average, equities research analysts predict that Sabra Healthcare REIT, Inc. will post 1.45 EPS for the current year.

Sabra Healthcare REIT Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, August 29th. Shareholders of record on Friday, August 15th were issued a dividend of $0.30 per share. The ex-dividend date was Friday, August 15th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 6.4%. Sabra Healthcare REIT's dividend payout ratio is 157.89%.

Analyst Ratings Changes

Several equities research analysts have issued reports on SBRA shares. Wells Fargo & Company lifted their price target on Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock an "overweight" rating in a research note on Wednesday, August 27th. BMO Capital Markets lifted their price target on Sabra Healthcare REIT from $19.00 to $22.00 and gave the stock a "market perform" rating in a research note on Monday, August 25th. Scotiabank lifted their price objective on Sabra Healthcare REIT from $19.00 to $20.00 and gave the stock a "sector perform" rating in a report on Monday, June 23rd. Truist Financial lifted their price objective on Sabra Healthcare REIT from $18.00 to $20.00 and gave the stock a "hold" rating in a report on Tuesday, September 2nd. Finally, JMP Securities lifted their price objective on Sabra Healthcare REIT from $20.00 to $22.00 and gave the stock a "market outperform" rating in a report on Wednesday, August 6th. One equities research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and four have given a Hold rating to the company's stock. According to MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $20.71.

Sabra Healthcare REIT Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.